Skip to main content
. 2020 Oct 30;10:1583. doi: 10.3389/fonc.2020.01583

Figure 2.

Figure 2

Percentages of patients receiving chemotherapy according to RS risk categories. 1.7%, 12.9%, and 66.4% of patients with low-, intermediate-, and high-risk RS were recorded with “Yes” of chemotherapy, respectively, while 98.3%, 87.1%, and 33.6% of patients with low-, intermediate-, and high-risk RS were recorded with “No/Unknown” of chemotherapy, respectively.